340B
340B Participation May Hamper Biosimilars Uptake
Are hospitals participating in the federal 340B Drug Pricing Program less motivated to prescribe biosimilars over ...
AUGUST 16, 2023
CMS Proposes One-Time $9 Billion Restitution To Fix Years of 340B Underpayments
One year after a 2022 Supreme Court decision that the CMS did not have the authority to lower reimbursement rates ...
AUGUST 9, 2023
340Bs Push Back On Abuses Cited In COA Report
The Community Oncology Alliance has accused some safety net hospitals of gaming a federal drug discount program to ...
NOVEMBER 10, 2021
Site Neutral Payment Reform Advocates Set Their Sights on 340B
Some days, Kashyap Patel, MD, wonders why in the world he decided to become an oncologist. Triple board-certified ...
JUNE 3, 2017
340B Drug Discount Program in Need of Reform
A recent Letter to the Editor defending the 340B drug discount program sidesteps the evidence showing it has become ...
APRIL 7, 2017
